Rheumatoid Arthritis clinical trials

34 trials changed in the last 30 days: 0 stopped, 14 with notable changes, 20 with minor changes only.

1. Notable

   MethMax · MAXimising the METHotrexate Therapy Potential · Active…MethMax · MAXimising the METHotrexate Therapy Potential · Active Rheumatoid Arthritis

   Primary and study completion pushed from Sep 30, 2026 to Jun 7, 2027

   Medical University of Vienna·Phase 4· NCT06649136· Registry history of NCT06649136 on ClinicalTrials.gov (opens the registry)

   Oct 6, 2026

2. Notable

   Pentoxifylline as Anti-Inflammatory · Rheumatoid Arthritis

   Primary completion pushed from May 30, 2026 to May 30, 2027

   Also in this update: Study completion pushed from Sep 30, 2026 to Sep 30, 2027

   Tanta University·Phase 2· NCT06998628· Registry history of NCT06998628 on ClinicalTrials.gov (opens the registry)

   Oct 5, 2026

3. Notable

   Faecal Microbiota Transplantation · Refractory Rheumatoid Arthritis

   Primary completion pushed from Jun 1, 2028 to Jun 30, 2031

   Also in this update: Recruitment opened; Study completion pushed from Dec 31, 2028 to Dec 31, 2031

   Peking Union Medical College Hospital·Phase 2· NCT07639177· Registry history of NCT07639177 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

4. Notable

   Different Targeted Therapies · Rheumatoid Arthritis

   Primary endpoint(s) modified

   Also in this update: Interventions modified; Trial arms changed: 12 → 6; and 4 more changes in the last 30 days

   AbbVie·Phase 2· NCT06972446· Registry history of NCT06972446 on ClinicalTrials.gov (opens the registry)

   Oct 8, 2026

5. Notable

   PROMESS_1 · National Cohort of Subjects at Risk of Developing…PROMESS_1 · National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

   Primary and study completion pushed from Dec 2027 to Dec 2029

   Also in this update: Recruitment opened; Interventions modified

   University Hospital, Montpellier·Not specified· NCT06876064· Registry history of NCT06876064 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

6. Notable

   Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel…Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis

   Primary endpoint(s) modified

   Fuller Research Foundation·Not applicable· NCT07524244· Registry history of NCT07524244 on ClinicalTrials.gov (opens the registry)

   Oct 5, 2026

7. Notable

   Regulation of Mucosal Healing in Inflammatory Bowel Disease

   Primary endpoint(s) modified

   Also in this update: Results posted: Sep 30, 2026; Trial completed

   Terrence A Barrett·Not applicable· NCT04504136· Registry history of NCT04504136 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

8. Notable

   BEN301 Injection · Autoimmune Diseases

   Enrollment reduced: 24 → 2 participants

   Also in this update: Recruitment opened; Primary and study completion moved earlier from Feb 28, 2029 to Apr 30, 2027

   Beijing Boren Hospital·Early Phase 1· NCT07502859· Registry history of NCT07502859 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

9. Notable

   Healthy Adult Participants and · Autoimmune Disease to Test How…Healthy Adult Participants and · Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body

   Recruitment opened

   Otsuka Pharmaceutical Development & Commercialization, Inc.·Phase 1· NCT07649265· Registry history of NCT07649265 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

10. Notable

    JAB-8263 · JAB-8263 · Active Rheumatoid Arthritis

    Recruitment opened

    Jacobio Pharmaceuticals Co., Ltd.·Phase 2· NCT07684157· Registry history of NCT07684157 on ClinicalTrials.gov (opens the registry)

    Sep 28, 2026

11. Notable

    TLL-018 · Moderate to Severe Active Rheumatoid Arthritis With…TLL-018 · Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs

    Enrolling by invitation only

    Hangzhou Highlightll Pharmaceutical Co., Ltd·Phase 2· NCT07748728· Registry history of NCT07748728 on ClinicalTrials.gov (opens the registry)

    Sep 28, 2026

12. Notable

    Pain Neuroscience Education and Vagus Nerve Stimulation on…Pain Neuroscience Education and Vagus Nerve Stimulation on Recovery · Rheumatoid Arthritis

    Recruitment opened

    Also in this update: Enrollment increased: 36 → 42 participants

    Medipol University·Not applicable· NCT07274124· Registry history of NCT07274124 on ClinicalTrials.gov (opens the registry)

    Oct 9, 2026

13. Notable

    Called PF-08154225 · Autoimmune Diseases

    Start date pushed from Oct 10, 2026 to Nov 19, 2026

    Pfizer·Phase 1/2· NCT07782450· Registry history of NCT07782450 on ClinicalTrials.gov (opens the registry)

    Oct 1, 2026

14. Notable

    Patient-Reported Outcomes Dashboard With Goal Setting to Support…Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis

    Start date pushed from Nov 16, 2026 to Jan 1, 2027

    Northwestern University·Not applicable· NCT07865390· Registry history of NCT07865390 on ClinicalTrials.gov (opens the registry)

    Oct 15, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.